Pricing Log in Create free account

Corcept Therapeutics Incorporated (CORT) vs Protagonist Therapeutics, Inc. (PTGX)

Corcept Therapeutics Incorporated and Protagonist Therapeutics, Inc. are both Biotechnology companies. Protagonist Therapeutics, Inc. is the larger, with a market value of $8.8B against $7.8B — 1.1× the size. Corcept Therapeutics Incorporated trades at the lower P/E: 47.5× against 111×. Protagonist Therapeutics, Inc. grew revenue faster over the last twelve months: 34.8% against 30.0%. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs 16.5%) and the higher return on invested capital (61.8% vs 15.0%). Across the 21 metrics below, Corcept Therapeutics Incorporated leads on 13 and Protagonist Therapeutics, Inc. on 8.

Valuation

Metric CORT PTGX Biotechnology median
P/E 47.47 110.95 10.26
P/S 7.98 31.65 9.18
P/B 9.22 10.61 2.05
Price to free cash flow 39.51 68.35 24.81
EV/EBITDA 67.42 144.60 0.65
EV/Sales 7.61 28.91 8.98
Earnings yield 2.11% 0.90% (34.89%)
Free cash flow yield 2.53% 1.46% (24.52%)

Profitability

Metric CORT PTGX Biotechnology median
Gross margin 98.54% 100.00% 65.16%
Operating margin 11.51% 20.69% 0.00%
Net margin 16.54% 29.40% 0.00%
Free cash flow margin 20.20% 46.31% 0.00%
Return on equity 21.74% 10.98% (50.12%)
Return on assets 17.16% 10.34% (45.60%)
Return on invested capital 14.97% 61.84% 0.00%

Growth

Metric CORT PTGX Biotechnology median
Revenue growth (TTM) 30.02% 34.81% 6.26%
EPS growth (last fiscal year) (33.33%) (148.46%) 29.88%
Revenue growth, 5-year CAGR 16.56% 9.96% 9.75%
Net income growth, 5-year CAGR (1.52%) 0.00% 0.00%

Health

Metric CORT PTGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.00 21.71 4.89
Net debt to EBITDA (8.83) 3.49 1.01

Dividend

Metric CORT PTGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CORT PTGX Biotechnology median
Market cap 7.84b 8.75b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack